PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för CNDAC. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

8 hits

Bibliografisk träff 2019-09-09

CNDAC-Induced DNA Double-Strand Breaks Cause Aberrant Mitosis Prior to Cell Death.

Liu X, Jiang Y, Takata KI, Nowak B, Liu C, Wood RD, Hittelman WN, Plunkett W.

Mol Cancer Ther · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1158/1535-7163.mct-18-1380

Bibliografisk träff 2017-11-30

Targeting BRCA1/2 deficient ovarian cancer with CNDAC-based drug combinations.

Liu X, Jiang Y, Nowak B, Qiang B, Cheng N, Chen Y, Plunkett W.

Cancer Chemother Pharmacol · research-article; journal article; research support, n.i.h., extramural · DOI 10.1007/s00280-017-3483-6

Bibliografisk träff 2017-08-11

TDP1 is Critical for the Repair of DNA Breaks Induced by Sapacitabine, a Nucleoside also Targeting ATM- and BRCA-Deficient Tumors.

Al Abo M, Sasanuma H, Liu X, Rajapakse VN, Huang SY, Kiselev E, Takeda S, Plunkett W, Pommier Y.

Mol Cancer Ther · research support, n.i.h., intramural; research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1158/1535-7163.mct-17-0110

Bibliografisk träff 2016-07-29

Mechanism-Based Drug Combinations with the DNA Strand-Breaking Nucleoside Analog CNDAC.

Liu X, Jiang Y, Nowak B, Hargis S, Plunkett W.

Mol Cancer Ther · research-article; journal article · DOI 10.1158/1535-7163.mct-15-0801

Bibliografisk träff 2012-09-23

Bone Marrow and Peripheral Blood AML Cells Are Highly Sensitive to CNDAC, the Active Form of Sapacitabine.

Jagan S, Paganessi LA, Frank RR, Venugopal P, Larson M, Christopherson KW.

Adv Hematol · research-article; journal article · DOI 10.1155/2012/727683

Bibliografisk träff 2012-06-26

Sapacitabine, the prodrug of CNDAC, is a nucleoside analog with a unique action mechanism of inducing DNA strand breaks.

Liu XJ, Nowak B, Wang YQ, Plunkett W.

Chin J Cancer · research-article; journal article; research support, n.i.h., extramural · DOI 10.5732/cjc.012.10077

Bibliografisk träff 2010-06-29

Influence of cytidine deaminase on antitumor activity of 2'-deoxycytidine analogs in vitro and in vivo.

Yoshida T, Endo Y, Obata T, Kosugi Y, Sakamoto K, Sasaki T.

Drug Metab Dispos · research support, non-u.s. gov't; journal article · DOI 10.1124/dmd.110.034397

Bibliografisk träff 1996-01-01

[Design of a new antitumor nucleoside CNDAC, against solid tumors].

Matsuda A.

Gan To Kagaku Ryoho · research support, non-u.s. gov't; journal article